Repligen Acquires Bioprocessing Analytics Portfolio from 908 Devices Inc., Amidst Market Volatility
908 Devices Inc. has recently been acquired by Repligen, with its stock price currently at $5.31 USD, reflecting a decline from its 52-week high and presenting challenges in profitability and valuation.
2 minutes to read